BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35834096)

  • 1. NKX3.1 Expression in Salivary Gland "Intraductal" Papillary Mucinous Neoplasm: A Low-Grade Subtype of Salivary Gland Mucinous Adenocarcinoma.
    Nakaguro M; Sadow PM; Hu R; Hattori H; Kuwabara K; Tsuzuki T; Urano M; Nagao T; Faquin WC
    Head Neck Pathol; 2022 Dec; 16(4):1114-1123. PubMed ID: 35834096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKX3.1 Expression and Molecular Characterization of Secretory Myoepithelial Carcinoma (SMCA): Advancing the Case for a Salivary Mucous Acinar Phenotype.
    Patel S; Wald AI; Bastaki JM; Chiosea SI; Singhi AD; Seethala RR
    Head Neck Pathol; 2023 Jun; 17(2):467-478. PubMed ID: 36746884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological evaluation of minor salivary gland papillary-cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm.
    Nakaguro M; Urano M; Ogawa I; Hirai H; Yamamoto Y; Yamaguchi H; Tanigawa M; Matsubayashi J; Hirano H; Shibahara J; Tada Y; Tsuzuki T; Okada Y; Sato Y; Ikeda K; Sukeda A; Honda Y; Mikami Y; Nagao T
    Histopathology; 2020 Feb; 76(3):411-422. PubMed ID: 31505033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary Mucinous Adenocarcinoma Is a Histologically Diverse Single Entity With Recurrent AKT1 E17K Mutations: Clinicopathologic and Molecular Characterization With Proposal for a Unified Classification.
    Rooper LM; Argyris PP; Thompson LDR; Gagan J; Westra WH; Jordan RC; Koutlas IG; Bishop JA
    Am J Surg Pathol; 2021 Oct; 45(10):1337-1347. PubMed ID: 33739781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
    Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
    Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucous Gland Adenoma of the Lung: A Neoplastic Counterpart of Mucinous Bronchial Glands.
    Sasaki E; Masago K; Kogure Y; Fujita S; Iwakoshi A; Kuroda H; Tsuzuki T; Tsuta K; Matsushita H; Oki M
    Mod Pathol; 2023 Jun; 36(6):100182. PubMed ID: 37028599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands.
    Skálová A; Hyrcza MD; Leivo I
    Head Neck Pathol; 2022 Mar; 16(1):40-53. PubMed ID: 35312980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
    Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gland papillary adenocarcinoma with intestinal-like features: Clinicopathologic, immunohistochemical, and genetic study of six cases.
    Liu X; Zhang Y; Zhou CX; Li TJ
    J Oral Pathol Med; 2022 Feb; 51(2):172-179. PubMed ID: 34982488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.
    Rezaee N; Barbon C; Zaki A; He J; Salman B; Hruban RH; Cameron JL; Herman JM; Ahuja N; Lennon AM; Weiss MJ; Wood LD; Wolfgang CL
    HPB (Oxford); 2016 Mar; 18(3):236-46. PubMed ID: 27017163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas].
    Ji Y; Tan YS; Zhu XZ; Zeng HY; Kuang TT; Jin DY
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):77-81. PubMed ID: 16630480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
    Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
    Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
    Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
    J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.
    Fukumura Y; Nakanuma Y; Kakuda Y; Takase M; Yao T
    Virchows Arch; 2017 Jul; 471(1):65-76. PubMed ID: 28550497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.
    Fukuda A
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):519-23. PubMed ID: 25900667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
    Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
    Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal papillary mucinous neoplasm of the pancreas: Cytomorphology, imaging, molecular profile, and prognosis.
    Geramizadeh B; Marzban M; Shojazadeh A; Kadivar A; Maleki Z
    Cytopathology; 2021 Jul; 32(4):397-406. PubMed ID: 33792980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
    Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
    Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous pancreatic solid pseudopapillary neoplasm and intraductal papillary mucinous neoplasm.
    Hirabayashi K; Zamboni G; Ito H; Ogawa M; Kawaguchi Y; Yamashita T; Nakagohri T; Nakamura N
    World J Gastroenterol; 2013 Jun; 19(21):3358-63. PubMed ID: 23745041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.